Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Core S&P 500 ETF (IVV) vs Nuwellis Inc (NUWE) Price & Performance

iShares Core S&P 500 ETFTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

iShares Core S&P 500 ETF vs Nuwellis Inc — how do they compare? iShares Core S&P 500 ETF trades at $775.98, while Nuwellis Inc trades at $1.4 (market cap $542.80K). The key difference: iShares Core S&P 500 ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

IVVNUWE
Sector
Broad Market / FactorTechnology
52-Week High
$776.81$220.50
52-Week Low
$634.93$1.42
Market Cap
$542.80K
Enterprise Value
-$1.27M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Core S&P 500 ETF

IVV, tracking the S&P 500, trades at $776.77, up 0.01% with a bullish technical signal from moving averages but overbought RSI readings. The ETF benefits from strong institutional interest, as First Bank & Trust increased its stake by 24.8% in Q2 2026 (SEC filing, August 11, 2026), while Financial Advisory Corp reduced holdings by 3.1%. Market sentiment is mixed amid record highs and inflation concerns, with JPMorgan raising its S&P 500 target to 8,000 (FXEmpire, August 10, 2026).

Outlook remains positive due to robust corporate earnings and AI-driven growth, but risks include high valuations and potential pullbacks. Investors should focus on long-term diversification benefits, with the dividend offering steady income. Key resistance is at $777, with support at $772.

Nuwellis Inc

NUWE trades at $1.41, down 0.7% on the day, with a bearish technical signal driven by moving averages. The company shows strong revenue growth, with preliminary Q2 2026 revenue up 14% year-over-year, but remains unprofitable with a net income margin of -217.22%. Recent developments include a reverse stock split, new CEO appointment, and expansion of its Aquadex platform into new pediatric markets. Cash flow from operations is negative, though recent financing activities have provided capital.

The outlook is mixed: growth initiatives and analyst support offer potential, but persistent losses and high cash burn pose significant risks. Investors should weigh the company's expansion against its financial sustainability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares Core S&P 500 ETF

IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.

Read more on IVV

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE